论文部分内容阅读
现代市场经济下,企业并购是实施资产重组和实现资源优化配置的有效手段。2014年以来国内几大涉及医药类的企业都宣布重组,并购将是医药行业今后的发展主题。目前,重庆市的制药企业也在逐步进行并购工作。但制药企业的并购最大的问题在于资金不足,导致企业重组与再造过程中的众多问题难以解决。本文以重庆华邦制药为例,针对重庆市制药企业并购的融资需求和融资环境,对其融资方式进行分析与合理的选择,以促进制药企业的发展。
Under the modern market economy, M & A is an effective way to implement the reorganization of assets and optimize the allocation of resources. Since 2014, several major domestic pharmaceutical companies have announced restructuring and M & A will be the future development theme of the pharmaceutical industry. At present, Chongqing’s pharmaceutical companies are also gradually mergers and acquisitions. However, the biggest problem of pharmaceutical companies mergers and acquisitions is the lack of funds, leading to many problems in the process of restructuring and reorganization of enterprises difficult to solve. Taking Chongqing Winbond Pharmaceutical as an example, aiming at financing needs and financing environment of M & A in Chongqing, this paper analyzes and rationally selects financing ways to promote the development of pharmaceutical companies.